What do systematic reviews say?

Moxifloxacin‐containing 4‐month ATT regimens vs standard 6‐month ATT regimen

Moxifloxacin‐containing 4‐month ATT regimens probably leads to higher relapse compared with standard 6‐month ATT regimen (moderate certainty).

• Shortened treatment regimens versus the standard regimen for drug‐sensitive pulmonary tuberculosis 2019 · Cochrane Headline outcomes only
  RR 3.56 [2.37, 5.37]
  3 studies · 2265 participants
  Moderate